Different antitumor effects of JPH 203 in gastrointestinal cancer cells
Yasuhide Muto(Social Welfare Organization Saiseikai Imperial Gift Foundation), Naohiko Anzai(Dokkyo Medical University), Tomomi Furihata(Chiba University), Yoshie Reien(Chiba University), Hanae Morio(Chiba University), Hisahiro Matsubara(Chiba University), Kousuke Higuchi(Chiba University), Kentarou Okunishi(Chiba University), S Sakamoto(Chiba University)
Proceedings for Annual Meeting of The Japanese Pharmacological Society
January 1, 2018
Cited by 0
Related Papers
<i>miR‐145</i>, <i>miR‐133a</i> and <i>miR‐133b</i>: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma
|International Journal of Cancer|2010|442
IFSO Worldwide Survey 2020–2021: Current Trends for Bariatric and Metabolic Procedures
|Obesity Surgery|2024|253
MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer
|British Journal of Cancer|2013|103
Tumor‐derived exosomes influence the cell cycle and cell migration of human esophageal cancer cell lines
|Cancer Science|2020|51
JPH203, a newly developed anti-cancer drug, shows a preincubation inhibitory effect on L-type amino acid transporter 1 function
|Journal of Pharmacological Sciences|2020|40